Business

Nova Leap Health Corp. Closes Private Placement and Retains Market Stabilization and Liquidity Services

(via TheNewswire) Halifax / TheNewswire / January 8, 2018 - NOVA LEAP HEALTH CORP . (T...

articleNova Leap Health Corp.January 8, 20184/company/nova-leap-health-corp/news/nova-leap-health-corp-closes-private-placement-and-retains-market-stabilization-and-liquidity-services
Nova Leap Health Corp. Closes Private Placement and Retains Market Stabilization and Liquidity Services

About this update from Nova Leap Health Corp.

[{"type":"text","content":"Nova Leap Health Corp. Closes Private Placement and Retains Market Stabilization and Liquidity Services(via TheNewswire)\n\n \nHalifax / TheNewswire / January 8, 2018- NOVA LEAP HEALTH CORP. (TSXV: NLH) (\"Nova Leap\" or the \"Company\"), a company focused on the home health care industry, closes its previously announced non-brokered private placement for proceeds of $475,000 by the sale of units of the Company at a price of $0.20 per unit. The proceeds from the private placement will be used for working capital purposes. \n\n\n \nEach unit is comprised of one common share of the Company and a one-half common share purchase warrant. Two half-warrants entitle the holder to acquire one common share of the Company for $0.35 for a period of 24 months from the closing date of this private placement. The common shares and warrants are subject to a 4 month hold period. Certain officers and directors of the Company subscribed for an aggregate of 1,507,500 units.\n\n\n \nIn connection with the offering, a finder's fee was paid consisting of a cash payment of $7,260 and 36,300 non-transferable finder's fee warrants. Each finder's fee warrant will be exercisable into one common share of the Company at $0.35 per share for a period of 24 months from the closing date. \n\n\n \nRetention of Market Stabilization and Liquidity Services\n\n\n \nNova Leap is pleased to announce that, subject to regulatory approval, it has retained Mackie Research Capital Corporation to provide its market stabilization and liquidity services to the Company in compliance with the policies and guidelines of the TSX Venture Exchange and other applicable legislation.\n\n\n \nMackie will trade shares of Nova Leap on the TSXV for the purposes of maintaining a reasonable market and improving the liquidity of Nova Leap's common shares. The agreement between Mackie and the Company may be terminated by either party with written notice of 60 days and the Company has agreed to pay Mackie $3,000 per month during the term, payable quarterly in advance. The Company and Mackie act at arm's length, but Mackie may provide investment banking services to Nova Leap and Mackie and/or its clients may have an interest, directly or indirectly, in the securities of Nova Leap. The agreement is principally for the purposes of maintaining market stability and liquidity for the Company's common...

More updates from Nova Leap Health Corp.